logo
We know next to nothing about 99 per cent of the world's insects: Here's why that's a problem

We know next to nothing about 99 per cent of the world's insects: Here's why that's a problem

Yahoo05-04-2025
Despite our outsized impact on the planet, humans are not the dominant species. For every person on Earth, there are approximately 1.4 billion insects. All together, they would weigh 70 times more than the total human population.
While insects are by far the most numerous and widespread class in the animal kingdom, woefully little is known about them. Since they're essential to food production, the regularly reported decline in key species is a cause of concern.
But does it really spell 'insectageddon'? According to a study led by the UK Centre for Ecology & Hydrology (UKCEH) and ZSL (Zoological Society of London), we just don't know.
According to the study, there are about a million known insect species around the world. Of these, just 12,100 species have been assessed under the IUCN Red List of Threatened Species.
Of those that have been assessed, 20 per cent are considered threatened. But given that less than one per cent of the species have been assessed, the study rightfully asks, 'What about the other 99 per cent?'
Little monitoring of insect species goes on outside of North America and Europe. In fact, the researchers say there is very little known about insects in parts of Asia and South America, and virtually no data at all for species in Africa.
This week, the UK Butterfly Monitoring Scheme revealed that 2024 was one of the worst years on record for butterflies. It's a similar story across Europe and North America.
Dragonflies and bees are also well-studied in these regions. Of the dragonfly family, 16 per cent are thought to be at risk of extinction. Studies have shown a loss of 60 per cent of the bee population since the 1990s.
But these are not the only pollinators in our environment, nor are they the only insects that are useful to our existence.
'There is a lot of interest in monitoring charismatic species such as bees and butterflies,' says Dr Rob Cooke, an ecological modeller at UKCEH and joint lead author of the study. 'But few people care about the supposedly unpleasant insects, even though they too provide benefits for us.'
Despite the creepy appearance of the humble earwig, they are excellent at pest control - particularly on fruit trees, where they remove aphids without damaging the fruit. The hated cockroach is incredibly important for soil health and decomposition. Yet, they're among the least well-studied of all insects worldwide.
Related
'A momentous day for nature': EU approves first-of-its-kind law that could bring back biodiversity
'Red flag': Bug splats on cars reveal a staggering drop in insect numbers over last 20 years
Undoubtedly, many insect species are in decline. Loss of habitat, use of pesticides and declining food sources mean it's tough to be an insect in the modern world.
But the authors stress that it's essential to increase our understanding of insect populations and how humans affect them, before it's too late.
'We need to find out whether insect declines are widespread and what's causing them,' says Cooke. 'The challenge is like a giant jigsaw puzzle where there are thousands of missing pieces, but we do not have decades to wait to fill these gaps and then act.'
The study authors have proposed a new framework for establishing how different drivers impact local species. Through combining multiple data sources, they hope to build up a better picture of the state of global insect health, despite the gaps in the available data.
'With a million described species, it would take too long to figure out what works best for each species,' explains Dr Charlotte Outhwaite of ZSL's Institute of Zoology, joint lead author of the study. 'Instead, we want to find large-scale actions that benefit the most insects. For this, we need to use all the available information we have.'
The next step is to begin testing this approach, using a range of research methods to model how different insect species respond to various threats. Extrapolating from their findings will help develop an understanding of the current health of the world's insect population.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Biogen sees potential in combining Alzheimer's and obesity drugs
Biogen sees potential in combining Alzheimer's and obesity drugs

Boston Globe

time21 hours ago

  • Boston Globe

Biogen sees potential in combining Alzheimer's and obesity drugs

Advertisement Biogen's looking to the growth of its Alzheimer's drug Leqembi to offset the decline of its multiple sclerosis franchise, which is facing competition from cheaper generic drugs. Biogen's new Alzheimer's drug is already facing competition from Eli Lilly & Co.'s Alzheimer's drug, which was approved in the US last year and has since captured around 30 percent of the market, according to analysts. Other companies are also circling. Novo is carrying out clinical trials to assess whether the main ingredient in diabetes drug Ozempic and weight-loss shot Wegovy might help people with early Alzheimer's disease. Research suggests that the weight-loss drug could slow Alzheimer's progression by impacting inflammation and vascular health. Results of Novo's late-stage trial are expected later this year. Advertisement Viehbacher noted that being overweight is a risk factor for Alzheimer's. He cautioned the Novo study 'is a fairly risky proposition,' adding that 'most of the experts we're talking to are not convinced that it will work.' 'It's logical if you have a weight-loss drug that you can see some benefit, but it's actually pretty hard to move the needle on the cognitive side,' Viehbacher added. Alzheimer's drug development has been riddled with failures, even when drugs looked promising in early studies. Leqembi is a partnership between Cambridge, Massachusetts-based Biogen and Japanese drugmaker Eisai Co. Biogen makes the active ingredient for Leqembi in Switzerland. The company then ships it to North Carolina, where it gets made into a product. President Donald Trump recently put a 39 percent tariff on imports from Switzerland. It's unclear whether this would impact Biogen's drug. Still, Viehbacher said the company has the ability to start producing the substance used to make Leqembi in North Carolina for the US market, while continuing to make it in Switzerland for outside the US. He said the company always intended to use its North Carolina facilities to make Leqembi and the potential move was not a direct response to Trump's tariff threats. Last month, Biogen announced it intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina's Research Triangle Park.

ThinkBio.Ai® and UST Partner to Strengthen AI Enablement Capabilities for Biopharma and Healthcare Organizations
ThinkBio.Ai® and UST Partner to Strengthen AI Enablement Capabilities for Biopharma and Healthcare Organizations

Business Wire

time6 days ago

  • Business Wire

ThinkBio.Ai® and UST Partner to Strengthen AI Enablement Capabilities for Biopharma and Healthcare Organizations

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- UST, a leading digital transformation solutions company, has partnered with an AI-powered solutions provider for biopharmaceutical and healthcare organizations. This strategic partnership will empower UST to more efficiently leverage its expertise in digital transformation and advanced solutions to complement innovative AI-powered R&D capabilities. Together, the companies will deliver transformative solutions that accelerate AI transformation journeys and improve outcomes for biopharma and healthcare organizations worldwide. Leveraging advanced in-house expertise in oncology, immunology, neurology, and cardiology, has developed a suite of AI-powered solutions to address critical challenges across pharma and biotech preclinical and clinical R&D pipelines. These include data-driven strategies to identify the most optimal treatments, salvaging failed drugs through repurposing or combination therapies, and improving clinical trial success through biomarker-driven patient stratification and digital twin-enabled trial matching. In addition, AI-enhanced Research Co-pilot (R-COP™) utilizes AI to extend the existing Laboratory Information Management System (LIMS) capabilities. Fully interoperable with existing infrastructure, this next-generation tool transforms routine processes into dynamic, insight-driven research operations. These solutions are designed to support biopharma companies and healthcare providers in accelerating innovation and improving patient care. biological and clinical insights are powered by experts and delivered through the BioThinkHub™ data platform, drawing from expertly curated data and knowledge from proprietary and public data sources. 'This partnership will bring our unique AI and knowledge-based transformation products and solutions for Research and Discovery (R&D) to UST's focus on digital transformation capabilities and building Gen AI solutions for different industries, including the life science sector. Together, we will build custom ecosystems to help clients and partners stay ahead in a well-regulated, dynamic, and competitive landscape,' said Pradeep Palazhi, Founder and Chief Executive Officer, 'We will integrate AI-powered R&D transformation solutions with UST's strengths in digital transformation and Gen AI across life sciences – pharma, biotech, and medical devices. This strategic collaboration will drive innovation, accelerate time-to-value, and deliver measurable impact across the research and development value chain for our customers,' said Anu Koshy, Life Science cluster leader, UST. About is a pioneering digital biology, AI, and healthcare-focused company dedicated to advancing healthcare through innovative digital tools and solutions. By merging bioscience and digital biology with next-generation AI technologies, strives to create impactful biotech and healthcare innovations accessible to a global audience. The company is based in California and is privately funded. currently has biotech, life sciences, and healthcare customers in the US, UK, and India and is involved in many research projects in the areas of Proteomics, Metabolomics, Biological Target Identification, Healthcare Foundation Models, Responsible AI, Spatial Biology, Transcriptomics, Clinical Decision Support, and Pathways and Precision Medicine. About UST: Since 1999, UST has worked side by side with the world's best companies to make a powerful impact through transformation. Powered by technology, inspired by people, and led by our purpose, we partner with our clients from design to operation. Our digital solutions, proprietary platforms, engineering, R&D, products, and innovation ecosystem turn core challenges into impactful, disruptive solutions. With deep industry knowledge and a future-ready mindset, we infuse expertise, innovation, and agility into our clients' organizations—delivering measurable value and positive lasting change for them, their customers, and communities around the world. Together, with 30,000+ employees in 30+ countries, we build for boundless impact—touching billions of lives in the process. Visit us at

Are Potatoes Healthy? 3 Surprising Benefits, From Fiber to Antioxidants
Are Potatoes Healthy? 3 Surprising Benefits, From Fiber to Antioxidants

Yahoo

time05-08-2025

  • Yahoo

Are Potatoes Healthy? 3 Surprising Benefits, From Fiber to Antioxidants

Potatoes are the most commonly consumed vegetable in the U.S., yet they often get a bad rap. Most are eaten the form of fries or chips, so many people consider them an unhealthy food. It doesn't have to be that way. Eating one medium-size potato a day can be part of a healthy diet and doesn't increase cardiometabolic risk — the chances of having diabetes, heart disease or stroke — as long as the potato is steamed or baked, and prepared without adding too much salt or saturated fat, research shows. One 2020 study found that consuming non-fried potatoes also led to higher potassium and fiber intake compared to eating refined grains, like white rice, white bread or pasta. 'Certainly eating chips or french fries should be discouraged, but there are healthy ways to prepare potatoes, so I do think that lumping them all together is a little bit unfair to the poor potato,' Emily Johnston, Ph.D., study co-author, told in 2020. 'We don't want people to fear the potato, but we want to make sure that they eat it in a healthful way and in a controlled portion size.' Research on Potatoes and Health For the 2020 study, researchers looked at the effect of eating potatoes every day, compared to eating the same number of calories in refined grains. They recruited 50 healthy adults, whose baseline blood pressure and arterial stiffness were measured at the start of the study, and whose blood samples were checked for fasting glucose, cholesterol, insulin and other markers. Those checks were repeated throughout the study. The participants were then randomly assigned to replace their usual main meal starchy side dish with a study side dish: either 200 calories worth of potatoes or refined grains, as prepared by the Metabolic Diet Study Center at Penn State. They ate this way every day for four weeks. After a break of at least two weeks, they switched to the opposite study side dish, eating it with their main meal every day for a month. Potato side dishes consisted of steamed or baked red, white and gold spuds. Refined grain options included Spanish rice, pasta, garlic bread and naan, Johnston, who is now a research assistant professor in NYU's department of medicine, said. All were prepared with minimal added salt, saturated fat or sugar, though some ingredients were minimally added for taste, including scallions, onions, breadcrumbs and cheese. There was no evidence eating potatoes increased fasting glucose levels, and there was no difference in cholesterol, insulin or other markers, the authors noted. All in all, there were no adverse cardiometabolic consequences. 'We certainly want people to eat more non-starchy vegetables because we know the average American intake is well below recommendations,' Johnston said. 'But starchy vegetables and refined grains do contribute some important nutrition as well. It's just that we need to make sure we eat them in balance.' The Alliance for Potato Research and Education, a non-profit funded by the potato industry, provided money for the study, but didn't have any say in any aspects of it, the authors wrote. Potatoes Nutrition According to the U.S. Food and Drug Administration, one medium potato contains: 100 calories 26 grams carbohydrates 2 grams of fiber 3 grams of protein 0 grams of fat 1 gram of sugar 620 milligrams of potassium (18% DV) 40 milligrams vitamin C (45% DV) Health Benefits of Potatoes Potatoes are high in many vitamins and minerals and when prepared by steaming, baking or roasting with the skin on, they can be a more nutritious option than refined carbs, research has found. Potassium Potatoes are a rich source of potassium, which is important for blood pressure regulation, but most Americans don't get enough of in their diet, Johnston said. Almost half of adults in the U.S. have hypertension, according to the Centers for Disease Control and Prevention. In Johnston's 2020 study, the participants' potassium was significantly higher when they ate potatoes, compared to refined grains Their diet quality was also higher, driven by a higher vegetable intake. Fiber White potatoes can pack in a surprising amount of fiber when eaten with the skin on. A medium potato with the skin on can have 2-4 grams of fiber, according to Mayo Clinic. The fiber is both soluble and insoluble, meaning it both feeds the good bacteria in the gut and helps keep you regular. Vitamin C A medium potato can have 20-40 milligrams of vitamin C, almost half of the daily recommended amount, according to Cleveland Clinic. Your body doesn't produce vitamin C so you need to get it from your diet. This micronutrient is an antioxidant that can reduce risk of disease, boost the immune system and increase collagen production, per UCLA Health. The Healthiest Ways to Eat Potatoes Make potatoes a side dish composing about one-fourth of your whole plate, Fernstrom advised. Be careful about the portion size: One medium potato is about the size of a computer mouse, Johnston noted. Restaurant baked potatoes can be much bigger, so consider eating half. Stick to baking, roasting or steaming: Boiling potatoes doesn't add any calories or fat, but it leaches potassium out of them. Frying is a nutritional deal-breaker. Whether you bake or microwave, keep the skin on to optimize the nutrients and fiber. Skip the extras: Don't load your potato up with butter, sour cream or bacon bits. Go easy on the salt. This article was originally published on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store